CTN-0144: Integrating MOUD in Nonmedical Community Settings (NIH HEAL Initiative)
Richard Schottenfeld, MD
Co-Principal Investigator
Howard University
Department of Psychiatry & Behavioral Health
richard.schottenfeld@Howard.edu
Niranjan Karnik, MD, PhD
Co-Principal Investigator
University of Illinois Chicago
Department of Psychiatry
nkarnik@uic.edu
Viviana Horigian, MD, MHA
Co-Principal Investigator
University of Miami Miller School of Medicine
vhorigian@med.miami.edu
A multisite effectiveness-implementation study will be conducted in four sites to evaluate interventions to improve engagement and retention in MOUD with buprenorphine treatment persons with Opioid Use Disorder (OUD) in urban neighborhoods with high overdose rates. The investigators hypothesize that treatment with the Better Together Integrated Collaborative Community MOUD care model (BT-MOUD) will result in better retention in treatment than standard-of-care MOUD with buprenorphine provided in the hub buprenorphine clinic only (HC-MOUD Only) through 24 weeks following randomization. BT-MOUD provides MOUD with buprenorphine in nonmedical community-based settings via telemedicine from a hub buprenorphine clinic combined with Recovery Guiding, a manual guided coaching developed for this approach, provided onsite in the community organization.
Funded by the NIH HEAL InitiativeSM.
Related Resources
Node Involvement
Lead Node(s):